← back to search

Jie Zhi

Hebei Medical University · CN
Area of research
Oncology · Molecular Biology
Research interest
Research interests include Gut microbiota and health, Cancer survivorship and care, Lymphoma Diagnosis and Treatment, and Pancreatic and Hepatic Oncology Research.
h-index
5
citations
108
works
15
NIH funding
primary concept
email

Recent publications

Metabolic communication in colorectal cancer liver metastasis: The role of l-glutamine and SLC3A2
International Immunopharmacology 2025cited by 1position: middledoi
<scp>SARS</scp>‐<scp>CoV</scp>‐2 Infection Aggravates Physical and Mental Health in Cancer Patients Compared to Co‐Living Individuals
Cancer Medicine 2025cited by 0position: middledoi
Metabolic Communication in Colorectal Cancer Liver Metastasis: The Role of L-Glutamine and Slc3a2
SSRN Electronic Journal 2024cited by 0position: middledoi
Deep learning model for predicting the survival of patients with primary gastrointestinal lymphoma based on the SEER database and a multicentre external validation cohort
Journal of Cancer Research and Clinical Oncology 2023cited by 9position: middledoi
Gut Microbiota Alteration Influences Colorectal Cancer Metastasis to the Liver by Remodeling the Liver Immune Microenvironment
Gut and Liver 2022cited by 70position: middledoi
Gut Microbiota Alteration Influences Colorectal Cancer Metastasis to the Liver By Remodeling the Liver Immune Microenvironment
Research Square 2021cited by 2position: middledoi
Effect of the Chinese Medicine YangZheng XiaoJi on Reducing Fatigue in Mice with Orthotopic Transplantation of Colon Cancer
Evidence-based Complementary and Alternative Medicine 2019cited by 9position: middledoi
Effects of PHA-665752 and vemurafenib combination treatment on in�vitro and murine xenograft growth of human colorectal cancer cells with BRAFV600E mutations
Oncology Letters 2018cited by 11position: firstdoi
Effects of PHA-665752 and Cetuximab Combination Treatment on In Vitro and Murine Xenograft Growth of Human Colorectal Cancer Cells with KRAS or BRAF Mutations
Current Cancer Drug Targets 2017cited by 6position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yitao Jia · Hebei Medical University9 papers (2017–2025)Zhongxin Li · Hebei Medical University6 papers (2017–2023)Zhaolong Zhao · Hebei Medical University3 papers (2017–2019)Wujie Zhao · Hebei General Hospital3 papers (2024–2025)Donghai Yang · South China University of Technology2 papers (2017–2018)Hua Mu · Dalian Medical University2 papers (2024–2025)Yamei Gao · Hebei General Hospital2 papers (2021–2022)Na Yuan · Chinese PLA General Hospital2 papers (2021–2022)Qiao Lu · Dalian Medical University2 papers (2021–2022)Feng Mo · Hunan Normal University2 papers (2024–2025)Qing Li · University of Groningen2 papers (2024–2025)Bo Feng · Hebei General Hospital2 papers (2017–2018)Xinjian Xu · Xinjiang Medical University2 papers (2021–2022)Zhifei Xin · Hebei Medical University2 papers (2024–2025)Yang Li · Hebei Medical University2 papers (2024–2025)Weijing Li · Hebei Medical University1 papers (2023–2023)Xiaoyan Li · Hebei General Hospital1 papers (2022–2022) · 1 papers (2022–2022) · 1 papers (2022–2022)Xiaojing Jia · Dalian Medical University1 papers (2025–2025)